MoneyWorks4Me

Cipla informs about press release

18 Nov 2020 Evaluate

Cipla has informed that it has enclosed press release dated 18th November 2020 titled ‘Cipla launches “Covi-G” for COVID-19 rapid antibody detection’.

The above information is a part of company’s filings submitted to BSE.


Cipla Share Price

1435.50 19.50 (1.38%)
20-Aug-2026 10:45 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1893.30
Dr. Reddys Labs. 1174.90
Cipla 1435.50
Lupin 2229.80
Zydus Lifesciences 1116.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: